Praxsyn’s Move of Corporate Headquarters to Nevada

Media/Investor Contact:

949-777-6112 ext 101

IRVINE, Calif., Feb. 15, 2017 -- Praxsyn Corporation (OTCQB: PXYN) is pleased to announce that Praxsyn’s corporate headquarters have been moved from Irvine, California to Las Vegas, Nevada.

The board of directors authorized the move of Praxsyn Corporation’s headquarters to Nevada in order to allow for the expansion of Praxsyn’s operations, the ability to secure a larger pharmacy facility in Nevada at a more competitive price, and the overall lower labor costs.

Greg Sundem, PXYN’s Chief Executive Officer, stated “I have moved to Nevada from California because I believe it is important to be physically at any new facility to oversee the day-to-day operations and to ensure a successful transition.”

The new facility provides ample space for collection operations; with our increased focus on products and services that will pay within a 30-day billing cycle.  By changing the business model to a type of business that collects in a shorter amount of time, the company will have a more fiscally responsible financial model than the long collection cycle.

About Praxsyn Corporation

Headquartered in Las Vegas, Nevada, Praxsyn Corporation is a holding company that finds solutions to fit the needs and goals of medical professionals and their patients.  Mesa Pharmacy, located in Irvine, California works to realize the vision of medical professionals to improve the lives of their patients. Mesa Pharmacy continues its operations and services in Irvine, California to provide patients with pharmaceutical treatments as prescribed by their doctors.  Additional company information can be found at

Forward-Looking Statements

Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to statements in this press release regarding Praxsyn Corporation’s move to Las Vegas, Nevada, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports as have been filed with the Securities and Exchange Commission.